Daily Equity Report 22 May 2019

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 22 NDMAY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK - Indian indices fell 1 percentastheyfailedtomaintainthestrongupmovewhich wasrecordedonMay20,onthebackonexitpollsforLok NIFTY Sabha Election2019.Atclose,theSensexwasdown382.87 CLOSE PREVIOUS pointsat38969.80,whileNiftywasdown119.20pointsat NIKKEI 11709.10. About 970 shares have advanced, 1560 shares declined,and160sharesareunchanged.TataMotors,BPCL, ZeeEntertainment,IndusIndBank andAdaniPortswerethe 2061.25 2055.71 toplosersontheNifty,whilegainerswereDrReddy’sLabs, SECTORIAL INDICES Bharti Infratel, Britannia Industries, Titan Company and RelianceIndustries.Allthesectoralindicesendedinredled byauto,bank,pharma,energy,infra,metal,energyandIT. GLOBALFACE CLOSE CHANGE (%) CNX 100 S&P CNX 500 9578.85 4804.80 ! CNX 200 6044.60 AsianMarket- Asianmarketsfinishedmixedasofthemost recent closingprices.TheShanghaiCompositegained1.23%, BANK NIFTY whiletheHangSengledtheNikkei225lower.Theyfell 0.47%and0.14%respectively. TOP GAINERS CLOSE CHANGE (%) ! U.S.Market– Northand SouthAmericanmarketsfinished mixedas ofthemostrecentclosingprices.TheBovespa 2.92 2.10 gained2.17%andtheIPCrose0.17%.TheS&P500lost 0.67%. TITAN 1.34 ! BRITANNIA 1.26 European markets – European markets are higher today withsharesinGermanyleadingtheregion.TheDAXisup 0.99%whileLondon'sFTSE100isup0.64%andFrance's TOP LOSERS CLOSE CHANGE (%) CAC40isup0.56%. 177.60 -6.60 346.80 -4.33 375.35 -4.20 ADANIPORT 386.55 -3.39 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND STRATEGY BUY ON DIPS SCRIPT CLOSE (%) 2.92 1.06 S3 S2 11557 R1 R2 11959 R3 12159 11356 11633 11758 11834 0.92 BAJFINANCE S1-11545 S2-11400 R1-11900 R2-12080 0.87 HINDUNILVR CLOSE (%) -6.60 TATAMOTR -3.06 -3.00 -2.60 IOC NET BUY (CR.) NET STRATEGY BUY ON DIPS SELL (CR) BULLISH PIVOT POINTS P 30563 7610.68 S1 R1 R2 R3 31873 29252 29908 30156 31218 RESISTANCE R1-30750 R2-31000 DII 5129.52 NSE TOTALS ADVANCE S NIFTY BANK NIFTY Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! ! GlenmarkPharmagetsUSFDAnodfor SolifenacinSuccinatetablets AlembicPharmareceivesUSFDA approvalforSolifenacinSuccinate Alembic Pharma, in its filing to the exchanges on Tuesday, informed that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA)SolifenacinSuccinateTablets,5mg,and10mg, reactingtothis,sharesofthecompanyclimbed1%on the BSE. The approved ANDA is therapeutically equivalenttothereferencelisteddrug(RLD),Vesicare Tablets, 5 mg, and 10 mg, of Astellas Pharma US, Inc. Solifenacin SuccinateTabletisa muscarinicantagonist indicated for the treatment ofoveractive bladder with symptoms of urge urinary incontinence, urgency, and urinaryfrequency. GlenmarkPharmaceuticalsInc.,USA(Glenmark)hasbeen grantedfinalapprovalbytheUnitedStatesFood&Drug Administration(USFDA)forSolifenacinSuccinateTablets, 5mgand10mg,agenericversionofVesicareTablets,5 mgand10mg1,ofAstellasPharmaUS,Inc.Accordingto IQVIAsales datafor the12-month period endingMarch 2019, the Vesicare Tablets, 5 mg and 10 mg market achieved annual sales of approximately $942.7 million. Glenmarks current portfolio consists of 154 products authorizedfordistributionintheU.S.marketplaceand58 ANDAs pendingapprovalwiththeU.S.FDA.Inadditionto theseinternalfilings,Glenmarkcontinuestoidentifyand exploreexternaldevelopmentpartnershipstosupplement and accelerate the growth of its existing pipeline and portfolio. ! GAILIndiatoconsider bonusissueonMay27 GAILIndia,initspressnotetotheexchanges,informed thatthecompanysboardwillmeetonMay27toconsider bonusissue."Theboardofdirectorswillalsoconsider,the auditedfinancialresultsforthequarter/yearendedon March312019andalsotoconsiderrecommendationof finaldividendforFY19,ifany,"thecompanysaidina pressnoteaftermarketshourstotheexchangeson Monday. ! BHELcommissionstwomoreunitsof Kaleshwaramproject BharatHeavyElectricalsLimited(BHEL)hassuccessfully commissionedtwomorepumpingunits(Units3&4)of116MW each,ofthe7x116MWKaleshwaramLiftIrrigationScheme(LIS) Package-6inTelangana.BHELhadearliercommissionedunits 1&2ofthesameprojectinApril2019.Significantly,thepumpfor eachunitisdesignedtolift89.16cumecs(cubicmetresper second)ofwaterby105.5metres. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NAME OF THE STOCK : SBILIFE DATE : 22/05/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENTADVICE: CALLCS CALL:- BUY SBILIFE IN CASH ABOVE 660 TGT 672 SL 648 RATIONALEFORARRIVINGINVESTMENTADVICE: TECHNICALVIEW: THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.